PFKFB2 Is Pivotal for Metabolic Flexibility and Differential Glucose Utilization.
Harold. Kylene M KM; Matsuzaki. Satoshi S; Pranay. Atul A; Zhu. Jie J; Faakye. Anna A; Humphries. Kenneth M KM
Key Findings
- Loss of PFKFB2 reduces cardiac mitochondrial flexibility and glucose oxidation
- O‑GlcNAcylation rises in fed hearts lacking PFKFB2 but normalizes when fasted
- Systemic glucose regulation is disturbed in fasted and stressed states when cardiac PFKFB2 is absent
Practical Outcomes
- The work highlights the importance of PFKFB2 for heart fuel switching and blood sugar control, but it does not provide any actionable supplement or protocol for enthusiasts. Until human data or interventions targeting PFKFB2 are available, there are no concrete steps to apply from this study.
Summary
Researchers deleted a heart‑specific enzyme called PFKFB2 in mice and found the hearts became less flexible at switching between fuels, showed altered glucose handling and changes in a protein modification called O‑GlcNAcylation, especially when the animals were fed. These effects also spilled over to affect blood sugar levels during fasting or stress. The study does not test any supplement or peptide, so it offers no direct actions for biohackers.
Abstract
The heart's constant energy demands make metabolic flexibility critical to its function as nutrient availability varies. The enzyme phosphofructokinase-2/fructose 2,6-bisphosphatase (PFKFB2) contributes to this flexibility by acting as a positive or negative regulator of cardiac glycolysis. We have previously shown that PFKFB2 is degraded in the diabetic heart and that a cardiac-specific PFKFB2 knockout (cKO) impacts ancillary glucose pathways and mitochondrial substrate preference. Therefore, defining PFKFB2's role in mitochondrial metabolic flexibility is paramount to understanding both metabolic homeostasis and metabolic syndromes. Further, it is unknown how PFKFB2 loss impacts the heart's response to acute stress. Here, we examined how cardiac mitochondrial flexibility and the posttranslational modification O-GlcNAcylation are affected in cKO mice in response to fasting or pharmacologic stimulation. cKO and litter-matched controls were euthanized in the fed or fasted (12 hours) states, with or without a 20-minute stimulant stress of caffeine and epinephrine. Mitochondrial respiration, metabolomics, and changes to systemic glucose homeostasis were evaluated. cKO mice had moderate impairment in mitochondrial metabolic flexibility, affecting downstream glucose oxidation, respiration, and carnitine palmitoyl transferase 1 activity. O-GlcNAcylation, a product of ancillary glucose metabolism, was upregulated in cKO hearts in the fed state, but this was ameliorated in the fasted state. Furthermore, metabolic remodeling in response to PFKFB2 loss was sufficient to impact circulating glucose in fasted and stressed states. PFKFB2 is essential for fed-to-fasted changes in cardiac metabolism and plays an important regulatory role in protein O-GlcNAcylation. Its loss also affects systemic glucose homeostasis under stressed conditions.
Study Information
pubmed
2025
2025-11-11T00:00:00.000Z
10.1161/jaha.125.043921